Arcadia Biosciences, Inc. (RKDA) › Capital ExpendituresArcadia Biosciences, Inc. (RKDA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $148.0K2015: $151.0K2016: $231.0K2017: $79.0K2018: $250.0K2019: $1.48M2020: $2.33M2021: $1.01M2022: $72.0K2023: $5.0K2024: $16.0K2025: $0$02014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$0-100.0%2024$16.0K+220.0%2023$5.0K-93.1%2022$72.0K-92.9%2021$1.01M-56.9%2020$2.33M+58.1%2019$1.48M+490.8%2018$250.0K+216.5%2017$79.0K-65.8%2016$231.0K+53.0%2015$151.0K+2.0%2014$148.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share